← Back to all stories
Health science US

Targeted Immune Therapy Completely Eliminates Aggressive Childhood Brain Cancer in Preclinical Trial

Good News Network
Targeted Immune Therapy Completely Eliminates Aggressive Childhood Brain Cancer in Preclinical Trial

Photo: National Cancer Institute / Unsplash

Researchers at UC San Francisco have developed a novel immune cell therapy that activates exclusively upon entering the brain to target aggressive childhood tumors. In early laboratory testing, the treatment successfully cleared cancer cells in all subjects while training the immune system to provide lasting protection against recurrence.

Researchers at UC San Francisco have developed a novel immune cell therapy that activates exclusively upon entering the brain to target aggressive childhood tumors. In early laboratory testing, the treatment successfully cleared cancer cells in all subjects while training the immune system to provide lasting protection against recurrence.

Read the full story at Good News Network